低剂量胺改善了治疗耐药抑郁症和自杀念头的患者的大脑网络完整性
Tung-Ping Su1, Li-Kai Cheng2, Pei-Chi Tu3
1Department of Psychiatry, Taipei Veterans General Hospital, Taipei, Taiwan; Division of Psychiatry, Faculty of Medicine, National Yang Ming Chiao Tung University, Taipei, Taiwan; Institute of Brain Science, National Yang Ming Chiao Tung University, Taipei, Taiwan; Department of Psychiatry, General Cheng Hsin Hospital, Taipei, Taiwan.
Psychiatry research
|January 31, 2025
概括
低剂量胺有效降低了治疗耐药抑郁症患者的抑郁和自杀症状. 这种抗抑郁药效应与大脑网络完整性的改善有关,特别是在丘脑和角性环中.
科学领域:
- 神经科学是一个神经科学.
- 精神病学是一个精神病学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 胺是用于治疗抑郁症的分离性药物.
- 胺抗抑郁药作用的神经功能机制尚未完全理解.
- 以前的研究表明,胺会影响大规模的大脑网络,如默认模式和突出网络.
研究的目的:
- 研究低剂量胺抗抑郁药对具有自杀念头的治疗耐药抑郁症 (TRD) 的抗抑郁作用的神经功能机制.
- 通过静止状态功能磁共振成像 (rs-fMRI) 检查胺对大脑网络完整性的影响.
主要方法:
- 43名TRD和SI患者接受了胺 (0.5毫克/公斤) 或米达佐 (0.045毫克/公斤) 输液.
- 用汉密尔顿抑郁症评分表和哥伦比亚自杀严重程度评分表来评估抑郁和自杀症状.
- rs-fMRI在基线和输注后3天进行,分析图形理论指标,如度中心性和聚类系数.
主要成果:
- 与米达佐拉姆相比,胺输液显著减少了抑郁 (p = 0.001) 和自杀 (p = 0.025) 症状.
- 胺改善了大脑网络的完整性,由增加的中心度和集群系数在角回路中证明.
- 在胺注入后,右丘脑中观察到中心度的增加.
结论:
- 在thalamus和默认模式网络 (角性环) 中的神经功能变化与胺在TRD患者的抗抑郁作用有关.
- 这些发现阐明了基他胺快速抗抑郁作用背后的大脑网络机制.
相关概念视频
Electroconvulsive Therapy
22
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
22
Antidepressant Drugs: MAOIs and Other Agents
183
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
183
Brain Imaging
203
Brain imaging technologies provide critical insights into both the structure and function of the human brain, enabling medical professionals and researchers to diagnose, study, and treat neurological disorders or psychiatric disorders more effectively.
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
These technologies include computerized axial tomography (CAT or CT scans), positron-emission tomography (PET scans), magnetic resonance imaging (MRI), functional magnetic resonance imaging (fMRI), and Transcranial Magnetic...
203
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Depression: Overview
210
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
210


